JNJ

238.23

-0.2%↓

UNH

273.19

-0.82%↓

TMO

539.43

-1.35%↓

ABT

112.32

+1.08%↑

ISRG

495.1

+0.46%↑

JNJ

238.23

-0.2%↓

UNH

273.19

-0.82%↓

TMO

539.43

-1.35%↓

ABT

112.32

+1.08%↑

ISRG

495.1

+0.46%↑

JNJ

238.23

-0.2%↓

UNH

273.19

-0.82%↓

TMO

539.43

-1.35%↓

ABT

112.32

+1.08%↑

ISRG

495.1

+0.46%↑

JNJ

238.23

-0.2%↓

UNH

273.19

-0.82%↓

TMO

539.43

-1.35%↓

ABT

112.32

+1.08%↑

ISRG

495.1

+0.46%↑

JNJ

238.23

-0.2%↓

UNH

273.19

-0.82%↓

TMO

539.43

-1.35%↓

ABT

112.32

+1.08%↑

ISRG

495.1

+0.46%↑

Search

Phreesia Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

12.38 1.98

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

12.23

Max

12.72

Pagrindiniai rodikliai

By Trading Economics

Pajamos

3.6M

4.3M

Pardavimai

3.1M

120M

Pelno marža

3.549

Darbuotojai

2,082

EBITDA

6.1M

13M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+130.33% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-03-11

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-469M

737M

Ankstesnė atidarymo kaina

10.4

Ankstesnė uždarymo kaina

12.38

Naujienos nuotaikos

By Acuity

63%

37%

295 / 352 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Neutral Evidence

Phreesia Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-02-10 23:26; UTC

Pagrindinės rinkos jėgos

Moderna Stock Slips After FDA Refuses Flu Vaccine Review

2026-02-10 22:31; UTC

Uždarbis

Correction to America Movil 4Q Profit Article

2026-02-10 22:22; UTC

Uždarbis

America Movil 4Q Profit Jumps on Lower Financial Costs

2026-02-10 23:51; UTC

Rinkos pokalbiai
Uždarbis

Commonwealth Bank's Margin Management Gives It a Platform -- Market Talk

2026-02-10 23:42; UTC

Rinkos pokalbiai

Gold Rises Amid Fed Rate-Cut Prospects -- Market Talk

2026-02-10 23:40; UTC

Rinkos pokalbiai
Uždarbis

Commonwealth Bank Bear Says 1H Result Looks Strong -- Market Talk

2026-02-10 23:21; UTC

Rinkos pokalbiai

Ford Says EV Shift Was Driven by Demand Changes -- Market Talk

2026-02-10 23:21; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-02-10 22:17; UTC

Rinkos pokalbiai

Australia's One Nation Now Commands Working Class Vote -- Market Talk

2026-02-10 22:15; UTC

Uždarbis

Humana Earnings Will Shed More Light on Medicare Prospects -- Barrons.com

2026-02-10 22:10; UTC

Uždarbis

Intact Financial 4Q Book Value Per Share Was C$107.35 >IFC.T

2026-02-10 22:10; UTC

Uždarbis

Intact Financial Raises Qtr Dividend to C$1.47 >IFC.T

2026-02-10 22:09; UTC

Uždarbis

Intact Financial 4Q Combined Ratio Was 85.9% >IFC.T

2026-02-10 22:09; UTC

Uždarbis

Intact Financial 4Q Adj EPS C$5.50 >IFC.T

2026-02-10 22:01; UTC

Uždarbis

Intact Financial 4Q EPS C$5.24 >IFC.T

2026-02-10 21:54; UTC

Uždarbis

James Hardie Industries Sees FY26 Total Adjusted EBITDA $1.232B to $1.263B >JHX

2026-02-10 21:53; UTC

Uždarbis

Robinhood Stock Tumbles as Crypto-Related Revenue Falls Short of Expectations -- Barrons.com

2026-02-10 21:51; UTC

Uždarbis

James Hardie Industries Sees FY26 Free Cash Flow at Least $200M

2026-02-10 21:51; UTC

Uždarbis

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

2026-02-10 21:51; UTC

Uždarbis

James Hardie Industries: Focused on the Achievement of $125 M Target >JHX

2026-02-10 21:51; UTC

Uždarbis

James Hardie Industries: Integration and Cost Synergies Ahead of Schedule >JHX

2026-02-10 21:51; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Evolution Net Debt A$362 Million at Dec. 31 Vs A$1.29 Billion Year Earlier

2026-02-10 21:50; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Evolution: Gearing 6% at Dec. 31, From 23% a Year Earlier

2026-02-10 21:50; UTC

Uždarbis

James Hardie Industries 3Q EPS 12c >JHX

2026-02-10 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-02-10 21:50; UTC

Uždarbis

James Hardie Industries 3Q Adj EPS 24c >JHX

2026-02-10 21:49; UTC

Uždarbis

James Hardie Industries 3Q Sales $1.24B >JHX

2026-02-10 21:49; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Evolution 1H Operating Mine Cash Flow a Record A$1.73 Billion

2026-02-10 21:48; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Evolution 1H Ebitda A$1.56 Billion, Up 59% On-Year

2026-02-10 21:47; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Evolution 1H Revenue A$2.79 Billion, Up 37% On-Year

Akcijų palyginimas

Kainos pokytis

Phreesia Inc Prognozė

Kainos tikslas

By TipRanks

130.33% į viršų

12 mėnesių prognozė

Vidutinis 28.1 USD  130.33%

Aukščiausias 35 USD

Žemiausias 22 USD

Remiantis 12 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Phreesia Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

12 ratings

12

Pirkti

0

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

25.23 / 25.61Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Neutral Evidence

Vidutinės trukmės periodas

Strong Bullish Evidence

Ilgalaikis periodas

Bullish Evidence

Rinkos nuotaikos

By Acuity

295 / 352 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Meškų rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Phreesia Inc

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.
help-icon Live chat